134 related articles for article (PubMed ID: 33342327)
1. Molecular Nodal Restaging Based on CEACAM5, FGFR2b and PTPN11 Expression Adds No Relevant Clinical Information in Resected Non-Small Cell Lung Cancer.
Macia I; Aiza G; Ramos R; Escobar I; Rivas F; Ureña A; Aso S; Rosado G; Rodriguez-Taboada P; Deniz C; Nadal E; Capella G
J Invest Surg; 2022 Feb; 35(2):315-324. PubMed ID: 33342327
[TBL] [Abstract][Full Text] [Related]
2. Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases.
Benlloch S; Galbis-Caravajal JM; Alenda C; Peiró FM; Sanchez-Ronco M; Rodríguez-Paniagua JM; Baschwitz B; Rojas E; Massutí B
Ann Oncol; 2009 Jan; 20(1):91-7. PubMed ID: 18664559
[TBL] [Abstract][Full Text] [Related]
3. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
[TBL] [Abstract][Full Text] [Related]
4. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.
Nosotti M; Falleni M; Palleschi A; Pellegrini C; Alessi F; Bosari S; Santambrogio L
Chest; 2005 Sep; 128(3):1539-44. PubMed ID: 16162755
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.
Dai CH; Li J; Yu LC; Li XQ; Shi SB; Wu JR
Tumour Biol; 2013 Apr; 34(2):1245-53. PubMed ID: 23355336
[TBL] [Abstract][Full Text] [Related]
6. Is tumor diameter a risk factor for occult N1 metastasis in patients with peripheral non-small cell lung cancer which is smaller than 3 cm?
Sayan M; Celik A; Kankoc A; Akarsu I; Aslan MT; Kurtoglu A; Ahmedova G; Tastepe AI
Updates Surg; 2023 Dec; 75(8):2335-2342. PubMed ID: 37382803
[TBL] [Abstract][Full Text] [Related]
7. Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis.
Izbicki JR; Passlick B; Hosch SB; Kubuschock B; Schneider C; Busch C; Knoefel WT; Thetter O; Pantel K
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):623-30. PubMed ID: 8800148
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.
Maeshima AM; Tsuta K; Asamura H; Tsuda H
Cancer; 2012 Sep; 118(18):4512-8. PubMed ID: 22282325
[TBL] [Abstract][Full Text] [Related]
9. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.
Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM
Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657
[TBL] [Abstract][Full Text] [Related]
10. Combination of CEACAM5, EpCAM and CK19 gene expressions in mediastinal lymph node micrometastasis is a prognostic factor for non-small cell lung cancer.
Süer H; Erus S; Cesur EE; Yavuz Ö; Ağcaoğlu O; Bulutay P; Önder TT; Tanju S; Dilege Ş
J Cardiothorac Surg; 2023 Jun; 18(1):189. PubMed ID: 37312199
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of the current Japanese nodal classification on outcomes in resected non-small cell lung cancer.
Ichinose J; Murakawa T; Hino H; Konoeda C; Inoue Y; Kitano K; Nagayama K; Nitadori JI; Anraku M; Nakajima J
Chest; 2014 Sep; 146(3):644-649. PubMed ID: 24811857
[TBL] [Abstract][Full Text] [Related]
12. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival.
Gu CD; Osaki T; Oyama T; Inoue M; Kodate M; Dobashi K; Oka T; Yasumoto K
Ann Surg; 2002 Jan; 235(1):133-9. PubMed ID: 11753052
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
[TBL] [Abstract][Full Text] [Related]
14. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.
D'Cunha J; Corfits AL; Herndon JE; Kern JA; Kohman LJ; Patterson GA; Kratzke RA; Maddaus MA
J Thorac Cardiovasc Surg; 2002 Mar; 123(3):484-91; discussion 491. PubMed ID: 11882819
[TBL] [Abstract][Full Text] [Related]
15. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of multi-level N2-positive non-small cell lung cancer according to lymph node staging using endobronchial ultrasound-transbronchial biopsy.
Yoon HY; Lee JC; Kim SW; Kim HR; Kim YH; Choi SH; Kim SS; Song SY; Choi EK; Jang SJ; Choi CM
Thorac Cancer; 2018 Jun; 9(6):684-692. PubMed ID: 29607613
[TBL] [Abstract][Full Text] [Related]
17. Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†.
Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Spaggiari L; Ratto GB; Filosso PL; Facciolo F
Eur J Cardiothorac Surg; 2019 Mar; 55(3):405-412. PubMed ID: 30202953
[TBL] [Abstract][Full Text] [Related]
18. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
19. A pragmatic approach to the diagnosis of nodal micrometastases in early stage non-small cell lung cancer.
Herpel E; Muley T; Schneider T; Palm E; Kieslich de Hol D; Warth A; Meister M; Storz K; Schnabel PA; Schirmacher P; Dienemann H; Hoffmann H
J Thorac Oncol; 2010 Aug; 5(8):1206-12. PubMed ID: 20581709
[TBL] [Abstract][Full Text] [Related]
20. KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients.
Wang XM; Zhang Z; Pan LH; Cao XC; Xiao C
Breast Cancer Res Treat; 2019 Apr; 174(2):375-385. PubMed ID: 30535933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
